Weed (BUDZ) Net Cash Flow Growth (5y) (2022 - 2026)
Weed (BUDZ) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Weed | 2.77 Mn | 2.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.74% |
| Dec 31, 2025 | 17.21% |
| Sep 30, 2025 | -15.23% |
| Jun 30, 2025 | 5.70% |
| Mar 31, 2025 | -121.97% |
| Dec 31, 2024 | 77.45% |
| Sep 30, 2024 | -25.41% |
| Jun 30, 2024 | -1.54% |
| Mar 31, 2024 | -72.95% |
| Dec 31, 2023 | -77.11% |
| Sep 30, 2023 | 23.59% |
| Jun 30, 2023 | -16.74% |
| Mar 31, 2023 | -31.60% |
| Dec 31, 2022 | -16.20% |
| Sep 30, 2022 | -6.44% |
| Jun 30, 2022 | -24.59% |